Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
CR Bard
Current Asset
=
Cash
+
Deposits
+
Liquid Assets
=
1.85 B
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.
In accordance with recently published financial statements CR Bard Inc has Current Asset of 1.85 B. This is 94.17% higher than that of Healthcare sector, and 251.08% higher than that of Medical Instruments and Supplies industry, The Current Asset for all stocks is 80.05% higher than the company.
Filter other Stocks by Current Asset
Specify Market Cap
Select Current Asset Range
Current Range
Indicate Industry
Click to run this filter
Filter Other Equities
Current Asset Comparison
CR Bard is rated fifth in current asset category among related companies.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE CR Bard Inc
0.17%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
